Effects of in utero exposure of C57Bl/6J mice to 2,3,7,8-tetrachlorodibenzop-dioxin on epidermal permeability barrier development and function

Environmental Health Perspectives

Volumn 122, Issue 10, 2014, Pages 1052-1058

  Muenyi, Clarisse S ^a   Carrion, Sandra Leon ^a   Jones, Lynn A ^a   Kennedy, Lawrence H ^a,c   Slominski, Andrzej T ^b   Sutter, Carrie H ^a   Sutter, Thomas R ^a  

^a University of Memphis   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNITED STATES NAVAL ACADEMY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2, 3, 7, 8 TETRACHLORODIBENZO PARA DIOXIN; CERAMIDE; CORN OIL; SKIN LIPID; UNCLASSIFIED DRUG; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; DANGEROUS GOODS; WATER;

ACANTHOSIS; ARTICLE; ATOPY; DERMOEPIDERMAL JUNCTION; ENVIRONMENTAL EXPOSURE; EPIDERMAL PERMEABILITY BARRIER; EPIDERMOLYTIC HYPERKERATOSIS; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HISTOLOGY; LIPID ANALYSIS; PERMEABILITY BARRIER; PHENOTYPE; PRENATAL DRUG EXPOSURE; SKIN PERMEABILITY; SKIN WATER LOSS; STRATUM CORNEUM; TRANSMISSION ELECTRON MICROSCOPY; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; DANGEROUS GOODS; DRUG EFFECTS; EPIDERMIS; FEMALE; FETUS DEVELOPMENT; KERATOSIS; METABOLISM; MOUSE; NEWBORN; PERMEABILITY; PHYSIOLOGY; PREGNANCY; SKIN; SKIN ABSORPTION; TIGHT JUNCTION; TOXICITY;

ANIMALS; ANIMALS, NEWBORN; EPIDERMIS; FEMALE; FETAL DEVELOPMENT; HAZARDOUS SUBSTANCES; KERATOSIS; MATERNAL EXPOSURE; MICE; MICE, INBRED C57BL; PERMEABILITY; PREGNANCY; SKIN; SKIN ABSORPTION; TETRACHLORODIBENZODIOXIN; TIGHT JUNCTIONS; WATER;

EID: 84907646462     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1308045     Document Type: Article

References (43)

1. Boguniewicz M, Leung DY. 2011. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 242(1):233–246.
2. De Benedetto A, Kubo A, Beck LA. 2012. Skin barrier disruption: a requirement for allergen sensitization? J Invest Dermatol 132(3 Pt 2):949–963.
3. De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C, et al. 2011. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol 127(3):773–786; doi:10.1016/j.jaci.2010.10.018.
4. Feingold KR. 2007. Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res 48(12):2531–2546.
5. Fujimaki H, Nohara K, Kobayashi T, Suzuki K, Eguchi-Kasai K, Tsukumo S, et al. 2002. Effect of a single oral dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin on immune function in male NC/Nga mice. Toxicol Sci 66(1):117–124.
6. Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y, et al. 2002. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1– deficient mice. J Cell Biol 156(6):1099–1111.
7. Hardman MJ, Moore L, Ferguson MW, Byrne C. 1999. Barrier formation in the human fetus is patterned. J Invest Dermatol 113(6):1106–1113.
8. Hardman MJ, Sisi P, Banbury DN, Byrne C. 1998. Patterned acquisition of skin barrier function during development. Development 125(8):1541–1552.
9. Ito T, Inouye K, Nohara K, Tohyama C, Fujimaki H. 2008. TCDD exposure exacerbates atopic dermatitis-related inflammation in NC/Nga mice. Toxicol Lett 177(1):31–37.
10. Kennedy LH, Sutter CH, Leon Carrion S, Tran QT, Bodreddigari S, Kensicki E, et al. 2013. 2,3,7,8-Tetrachlorodibenzo-p-dioxinmediated production of reactive oxygen species is an essential step in the mechanism of action to accelerate human keratinocyte differentiation. Toxicol Sci 132(1):235–249.
11. Kim JS, Lim HS, Cho SI, Cheong HK, Lim MK. 2003. Impact of Agent Orange exposure among Korean Vietnam veterans. Ind Health 41(3):149–157.
12. Kimata H. 2003. 2,3,7,8-tetrachlorodibenzo-p-dioxin selectively enhances spontaneous IgE production in B cells from atopic patients. Int J Hyg Environ Health 206(6):601–604.
13. Kinoshita H, Abe J, Akadegawa K, Yurino H, Uchida T, Ikeda S, et al. 2006. Breakdown of mucosal immunity in gut by 2,3,7,8-tetraclorodibenzo-p-dioxin (TCDD). Environ Health Prev Med 11(5):256–263.
14. Kirschner N, Houdek P, Fromm M, Moll I, Brandner JM. 2010. Tight junctions form a barrier in human epidermis. Eur J Cell Biol 89(11):839–842.
15. Kuramoto N, Takizawa T, Takizawa T, Matsuki M, Morioka H, Robinson JM, et al. 2002. Development of ichthyosiform skin compensates for defective permeability barrier function in mice lacking transglutaminase 1. J Clin Invest 109(2):243–250.
16. Loertscher JA, Lin TM, Peterson RE, Allen-Hoffmann BL. 2002. In utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin causes accelerated terminal differentiation in fetal mouse skin. Toxicol Sci 68(2):465–472.
17. Loertscher JA, Sattler CA, Allen-Hoffmann BL. 2001. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters the differentiation pattern of human keratinocytes in organotypic culture. Toxicol Appl Pharmacol 175(2):121–129.
18. Luebke RW, Copeland CB, Daniels M, Lambert AL, Gilmour MI. 2001. Suppression of allergic immune responses to house dust mite (HDM) in rats exposed to 2,3,7,8-TCDD. Toxicol Sci 62(1):71–79.
19. Menon GK, Cleary GW, Lane ME. 2012. The structure and function of the stratum corneum. Int J Pharm 435(1) 3–9.
20. Morita K, Miyachi Y, Furuse M. 2011. Tight junctions in epidermis: from barrier to keratinization. Eur J Dermatol 21(1):12–17.
21. Müller FB, Huber M, Kinaciyan T, Hausser I, Schaffrath C, Krieg T, et al. 2006. A human keratin 10 knockout causes recessive epidermolytic hyperkeratosis. Hum Mol Genet 15(7):1133–1141.
22. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. 2006. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38(4):441–446.
23. Panteleyev AA, Bickers DR. 2006. Dioxin-induced chloracne—reconstructing the cellular and molecular mechanisms of a classic environmental disease. Exp Dermatol 15(9):705–730.
24. Panteleyev AA, Thiel R, Wanner R, Zhang J, Roumak VS, Paus R, et al. 1997. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCCD) affects keratin 1 and keratin 17 gene expression and differentially induces keratinization in hairless mouse skin. J Invest Dermatol 108(3):330–335.
25. Proksch E, Brandner JM, Jensen JM. 2008. The skin: an indispensable barrier. Exp Dermatol 17(12):1063–1072.
26. Puhvel SM, Sakamoto M. 1988. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on murine skin. J Invest Dermatol 90(3):354–358.
27. Ramot Y, Nyska A, Lieuallen W, Maly A, Flake G, Kissling GE, et al. 2009. Inflammatory and chloracne-like skin lesions in B6C3F1 mice exposed to 3,3´,4,4´-tetrachloroazobenzene for 2 years. Toxicology 265(1–2):1–9.
28. Reichelt J, Doering T, Schnetz E, Fartasch M, Sandhoff K, Magin TM. 1999. Normal ultrastructure, but altered stratum corneum lipid and protein composition in a mouse model for epidermolytic hyperkeratosis. J Invest Dermatol 113(3):329–334.
29. Schmuth M, Yosipovitch G, Williams ML, Weber F, Hintner H, Ortiz-Urda S, et al. 2001. Pathogenesis of the permeability barrier abnormality in epidermolytic hyperkeratosis. J Invest Dermatol 117(4):837–847.
30. Schulz VJ, Smit JJ, Willemsen KJ, Fiechter D, Hassing I, Bleumink R, et al. 2011. Activation of the aryl hydrocarbon receptor suppresses sensitization in a mouse peanut allergy model. Toxicol Sci 123(2):491–500.
31. Schulzke JD, Ploeger S, Amasheh M, Fromm A, Zeissig S, Troeger H, et al. 2009. Epithelial tight junctions in intestinal inflammation. Ann NY Acad Sci 1165:294–300.
32. Sugawara T, Iwamoto N, Akashi M, Kojima T, Hisatsune J, Sugai M, et al. 2013. Tight junction dysfunction in the stratum granulosum leads to aberrant stratum corneum barrier function in claudin-1-deficient mice. J Dermatol Sci 70(1):12–18.
33. Sutter CH, Bodreddigari S, Campion C, Wible RS, Sutter TR. 2011. 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases the expression of genes in the human epidermal differentiation complex and accelerates epidermal barrier formation. Toxicol Sci 124(1):128–137.
34. Sutter CH, Yin H, Li Y, Mammen JS, Bodreddigari S, Stevens G, et al. 2009. EGF receptor signaling blocks aryl hydrocarbon receptor-mediated transcription and cell differentiation in human epidermal keratinocytes. Proc Natl Acad Sci USA 106(11):4266–4271.
35. Tarkowski M, Kur B, Nocun M, Sitarek K. 2010. Perinatal exposure of mice to TCDD decreases allergic sensitization through inhibition of IL-4 production rather than T regulatory cell-mediated suppression. Int J Occup Med Environ Health 23(1):75–83.
36. Tauchi M, Hida A, Negishi T, Katsuoka F, Noda S, Mimura J, et al. 2005. Constitutive expression of aryl hydrocarbon receptor in keratinocytes causes inflammatory skin lesions. Mol Cell Biol 25(21):9360–9368.
37. Tran QT, Kennedy LH, Leon Carrion S, Bodreddigari S, Goodwin SB, Sutter CH, et al. 2012. EGFR regulation of epidermal barrier function. Physiol Genomics 44(8):455–469.
38. Tsai JC, Weiner ND, Flynn GL, Ferry J. 1991. Properties of adhesive tapes used for stratum corneum stripping. Int J Pharmaceutics 72:227–231.
39. Tunggal JA, Helfrich I, Schmitz A, Schwarz H, Gunzel D, Fromm M, et al. 2005. E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. Embo J 24(6):1146–1156.
40. Turksen K, Troy TC. 2002. Permeability barrier dysfunction in transgenic mice overexpressing claudin 6. Development 129(7):1775–1784.
41. Uchida Y, Holleran WM. 2008. Omega-O-acylceramide, a lipid essential for mammalian survival. J Dermatol Sci 51(2):77–87.
42. van den Bogaard EH, Bergboer JGM, Vonk-Bergers M, van Vlijmen-Willems IMJJ, Hato SV, van der Valk PGM, et al. 2013. Coal tar induces AHR-dependent skin barrier repair in atopic deramtitis. J Clin Invest 123(2):917–927.
43. Xiao C, Puddicombe SM, Field S, Haywood J, Broughton-Head V, Puxeddu I, et al. 2011. Defective epithelial barrier function in asthma. J Allergy Clin Immunol 128(3):549–556; doi:10.1016/j.jaci.2011.05.038.